Can You Say Your Disinfectant Kills Ebola in Canada? The Biocides Rules Nobody Is Explaining

When the World Health Organization declares a health emergency, disinfectant demand rises within days. Hospitals, food premises, schools and institutional buyers all start asking the same question: does this product kill the virus in the headlines? For Canadian manufacturers, the honest answer is more complicated than the marketing team would like, and getting it wrong is now an enforceable advertising offence.

On 17 May 2026, the WHO determined that the Ebola outbreak caused by Bundibugyo virus in the Democratic Republic of the Congo and Uganda was a Public Health Emergency of International Concern. Canadian border measures followed, and the questions about virucidal claims arrived with them. At the same time, the rules that govern those claims have quietly changed. Surface disinfectants and sanitizers are no longer regulated the way they were even two years ago. This article explains what you can and cannot say about a product's effectiveness against Ebola in Canada, and it walks through the Biocides Regulations transition that every disinfectant licence holder needs to plan for now.

Executive summary

For readers who need the bottom line before the detail, here are the points that matter most.

• Canada now regulates surface disinfectants and sanitizers under a single framework, the Biocides Regulations (SOR/2024-110), in force since 31 May 2025.
• Existing DIN disinfectants and registered sanitizers must transition by 31 May 2029. Health Canada recommends filing the transition application by 16 January 2029, and that application is free and requires no safety or efficacy data.
• Health Canada accepts an indirect virucidal claim only during a pandemic declared by the WHO. A Public Health Emergency of International Concern is not a pandemic declaration, so the indirect pathway is not open for Ebola right now.
• A direct virucidal claim is always possible, but it requires product-specific efficacy data using an approved test method such as ASTM E1053.
• Surface sanitizers used in food premises are not eligible for the free transition pathway unless they also carry disinfectant claims with a DIN. They need a full market authorisation by 31 May 2031.

What the Biocides Regulations changed, and why it matters

In short: Canada replaced two separate regimes for surface disinfectants and sanitizers with one. Until 31 May 2025, a surface disinfectant was a drug with a Drug Identification Number (DIN) under the Food and Drug Regulations, while a surface sanitizer was often registered as a pest control product under the Pest Control Products Act. The Biocides Regulations (SOR/2024-110) fold both into a single authorisation framework under the Food and Drugs Act. If your product destroys or inactivates micro-organisms on a hard, non-living surface, it is now a biocide and it needs a biocide market authorisation.

The Biocides Regulations were registered on 31 May 2024 and published in the Canada Gazette, Part II on 19 June 2024. They introduce requirements tailored to biocides, including record retention, packaging and labelling, post-authorisation changes, and post-market safety monitoring and incident reporting. The practical effect is that a product line that was compliant under the old DIN rules is not automatically compliant under the new ones. The table below sets out the shift.

The transition timeline every disinfectant holder must know

In short: you have until 31 May 2029 to transition an existing disinfectant, but you should file by 16 January 2029. Under Health Canada's transition guidance, a company that holds a DIN disinfectant or a PCPA-registered sanitizer can file an abbreviated transition application. That application requires no safety or efficacy data and carries no cost recovery fee, and the same 8-digit number is reissued. Health Canada recommends filing at the latest 135 days before the transition ends, which is 16 January 2029, so that there is time to review and issue a decision.

Miss that recommended date and the tone changes. Health Canada states that applications received after 16 January 2029 will trigger a letter setting out the risks and consequences, which can include paying a fee for examination of a new application and being unable to import, sell or advertise the biocide until a market authorisation is obtained. After 31 May 2029, DINs and pest control product registrations are no longer valid for biocides, and the transition pathway closes for good.

Can you claim your disinfectant kills Ebola? Direct versus indirect claims

In short: you can make an Ebola claim only if you hold direct efficacy data for it, because the indirect pathway is closed without a WHO-declared pandemic. Health Canada recognises two kinds of efficacy claim. A direct claim is causal and data-backed: you tested the product against the named organism and it worked. An indirect claim is relationship-based: you did not test the exact organism, but you tested one that is similar or harder to kill, so the product is likely to work against the new one. The two are treated very differently.

The distinction is decisive for Ebola. Health Canada's efficacy guidance for hard-surface disinfection and sanitization states plainly that indirect claims are only accepted during a pandemic declared by the World Health Organization. That single sentence decides what most companies can lawfully say right now.

Why a PHEIC does not open the indirect pathway

A PHEIC and a pandemic are different legal determinations under the International Health Regulations. The WHO PHEIC determination of 17 May 2026 is a signal that an event is serious, sudden and requires coordinated international response. It is not the pandemic declaration that Health Canada's guidance ties the indirect pathway to. Even though Canadian border measures are in place, the wording of the efficacy guidance has not changed. Until the WHO uses the word pandemic, an indirect Ebola claim is not available, and a company that makes one is exposed on advertising and on its market authorisation.

The two Health Canada pages that appear to contradict each other

There is a second source of confusion. Health Canada's surface disinfectants for emerging viral pathogens page, last modified on 18 November 2025, still describes disinfectants as drug products with a DIN and makes no reference to the Biocides Regulations. It names SARS-CoV-2 and mpox as enveloped-virus examples and lets manufacturers on the emerging viral pathogen list reference existing non-enveloped virus data and state how effective they believe their product is against the emerging virus. It does not mention Ebola, filoviruses, or the new biocide framework. Reading the two pages side by side, a manufacturer could reasonably reach two different conclusions. The safe reading is the strict one: no direct data means no Ebola claim, and the emerging viral pathogen list is not a shortcut around that.

What Health Canada requires to prove a virucidal claim

In short: a direct virucidal claim needs product-specific data using an approved method, and confirmatory testing uses the hardest-to-kill virus on the label. Viruses are not equally easy to inactivate. Health Canada groups them by resistance. Small non-enveloped viruses are the hardest to kill, large non-enveloped viruses sit in the middle, and enveloped viruses are the easiest. Ebola is an enveloped filovirus, so it sits in the lowest-resistance tier. That sounds reassuring, but it does not mean you can claim it without data. It means that if you test against the hardest-to-kill virus on your label, you can bridge the easier claims from that single confirmatory result.

The recognised test method for virucidal efficacy is ASTM E1053, or a modified version of it, with a separate method for towelette wiping. Broad-spectrum virucide claims call for two separately compounded batches per virus, testing at the lower certified limit against the hardest-to-kill labelled virus, and quadruplicate determinations. Where a live virus is difficult to culture, Health Canada permits only a short list of surrogate organisms, for example feline calicivirus as a surrogate for norovirus. The lesson for a claims strategy is simple: design the study around the hardest virus you want to name, keep the batches and carriers to specification, and let the science carry the label rather than the other way around.

Compliance checklist: biocide claims and transition readiness

• Confirm whether each product is a disinfectant, a sanitizer, or a food-premises surface sanitizer, because the category sets your pathway and deadline.
• List every DIN and pest control product registration in your portfolio and map each to a transition application or a new application.
• Diarise 16 January 2029 as your internal filing target and 31 May 2029 as the hard deadline for existing disinfectants and sanitizers.
• Flag any food-premises surface sanitizer without a DIN, since it cannot use the free transition pathway and needs a full market authorisation by 31 May 2031.
• Audit every virucidal claim on labels, websites and sales material against the direct-versus-indirect test, and remove any claim you cannot support with data.
• Do not rely on the emerging viral pathogen list or a PHEIC to justify an Ebola claim, because neither opens the indirect pathway.
• Confirm your efficacy studies use ASTM E1053 with the correct batch, carrier and replicate counts for the hardest-to-kill virus you intend to name.
• Build the biocide record retention, post-authorisation change and incident reporting procedures the regulations now require, and align your SOPs to them.

Common mistakes we see

Treating 2029 as far away. The free, data-light transition pathway is a gift, but it disappears on 31 May 2029, and the sensible filing target is 16 January 2029. Firms that wait risk paying for a full new application and losing the ability to sell in the meantime.

Assuming a food-premises sanitizer transitions the same way. Surface sanitizers used in food premises are not eligible for the abbreviated transition unless they also hold a DIN for disinfectant claims. They need a full market authorisation with data, and their deadline is 31 May 2031. This is the most expensive surprise in the framework.

Reading a PHEIC as a green light. A Public Health Emergency of International Concern feels like a pandemic in the news, but it is not the WHO-declared pandemic that Health Canada's guidance requires for an indirect claim. Sales teams often miss this distinction, and the exposure sits with the market authorisation holder.

Under-powering the efficacy study. Broad-spectrum claims need the right number of batches, carriers and replicate determinations against the hardest-to-kill virus. Studies that cut corners here fail review and delay the entire submission.

Frequently asked questions

Is a PHEIC the same as a pandemic for disinfectant claims?

No. Health Canada permits an indirect virucidal claim only during a pandemic declared by the WHO. The Ebola outbreak was declared a Public Health Emergency of International Concern on 17 May 2026, which is a different determination and not a pandemic declaration, so the indirect pathway is not open.

Can I say my disinfectant kills Ebola in Canada right now?

Only if you hold direct efficacy data showing the product inactivates Ebola virus using an approved method. Without that data, you cannot rely on an indirect claim, because there is no WHO-declared pandemic. Marketing an unsupported Ebola claim is an unsubstantiated advertising claim and is enforceable.

Do I still need a DIN for my disinfectant?

Yes, for now. Existing disinfectants keep their DIN and stay subject to the Food and Drug Regulations until the transition application receives a decision. After 31 May 2029, DINs and pest control product registrations are no longer valid for biocides, so you must transition before then.

Is the biocide transition application free?

Yes. A transition application under the Biocides Regulations requires no safety or efficacy data and carries no cost recovery fee, and the same 8-digit number is reissued. The pathway is only available during the transition period and closes on 31 May 2029.

What happens if I miss the deadline?

If you file after 16 January 2029, Health Canada will send a letter outlining the risks and consequences, which can include a fee for a new application and being unable to import, sell or advertise the product until it is authorised. After 31 May 2029, the transition pathway is gone and a full new application is required.

What test method does Health Canada require for virucidal claims?

Health Canada recognises ASTM E1053, or a modified version of it, for virucidal efficacy on hard surfaces, with a separate approach for towelette products. Broad-spectrum claims require multiple compounded batches, testing at the lower certified limit against the hardest-to-kill labelled virus, and replicate determinations.

How MFLRC can help

MFLRC provides senior-led pharmaceutical regulatory support and regulatory affairs, licensing and import and export services for Canadian and international manufacturers. For the Biocides Regulations, that means preparing transition applications, building market authorisation submissions for new biocides and food-premises sanitizers, and designing claim substantiation strategies that hold up under review.

We also run regulatory gap assessments against SOR/2024-110, review labelling for compliance, and build the record retention, incident reporting and post-authorisation change procedures the regulations now require. Our quality control services, audit and gap assessment services and food and beverage compliance support connect the biocide file to the wider quality system, so the transition strengthens your operation rather than adding a silo.

If you want to prepare more broadly, our guides on Health Canada GMP inspection readiness, writing SOPs that pass a Health Canada inspection and supplier qualification programmes all connect directly to a clean biocide submission.

The abbreviated transition application is free, requires no efficacy data, and disappears on 31 May 2029. If you are unsure whether your product transitions or needs a full market authorisation, or whether a virucidal claim is defensible, one review can settle it.

Conclusion

The Ebola PHEIC has put a hard question in front of Canadian disinfectant makers, and the answer runs through two things at once: what you can claim today, and how your products are regulated tomorrow. On claims, the rule is strict and clear. Without direct data, an Ebola claim needs a WHO-declared pandemic, and a PHEIC is not one. On regulation, the Biocides Regulations have already changed the ground under every disinfectant and sanitizer, and the free transition window closes on 31 May 2029. Companies that treat both issues as a single, planned project will protect their market access and their brand. Those that improvise will find that the rules were checkable all along.

Sources and references

• Biocides Regulations (SOR/2024-110), Justice Laws Website
• Canada Gazette, Part II, Biocides Regulations, 19 June 2024
• Health Canada, Guidance on the transition of disinfectants and surface sanitizers to the Biocides Regulations: Overview
• Health Canada, Guidance on efficacy requirements for biocides: Hard-surface disinfection and sanitization
• Health Canada, Surface disinfectants for emerging viral pathogens
• WHO, Ebola disease in the DRC and Uganda determined a Public Health Emergency of International Concern, 17 May 2026
• Public Health Agency of Canada, Ebola disease: Border measures for travellers entering Canada